| |
|
|
|
Clearside Biomedical- Inc.  
|
|
6.77 -0.2 (-0.03%) |
08-17 16:00 |
|
Open: |
6.96 |
Pre close: |
6.97 |
Target:
|
10.71 
|
|
High: |
7.07 |
Low: |
6.66 |
Resistance:
|
9.17
10.83
|
|
Volume: |
140,885 |
Market Cap: |
217M |
Support:
|
6.48
5.39
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.00
|
MACD |
MACD(12,26):
|
-0.83 |
|
MA(20): |
8.08 |
Signal(12,26,9): |
-0.77 |
|
MA(100): |
10.51 |
Stochastic Oscillator |
%K(14,3):
|
13.66  |
|
MA(250): |
8.75 |
%D(3): |
9.99 |
|
Average Volume(K) |
3-Month: |
40220
|
52-Week |
High:
|
15.33 |
|
10-Days: |
27954 |
Low: |
5.30 |
|
RSI |
RSI(14):
|
26.24 |
Change(%): |
0.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.640 |
Return on Equity (ttm) |
-119.2 |
Shares Out. (M) |
32.02 |
|
EPS Est. Current Year |
-2.100 |
Return on Assets (ttm) |
-92.2 |
Shares Float (M) |
31.39 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.00 |
|
EPS Est. Next Quarter |
-0.590 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
65.20 |
|
Forward EPS |
-2.080 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1188 |
|
Book Value (p.s.) |
3.650 |
EBITDA (p.s.) |
-0.567 |
P/E |
-2.56 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.85 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-55.76 |
P/S |
21630148608.00 |
|
Operating Margin |
-19001.47 |
Levered Free Cash Flow
(M) |
-31.68 |
P/CF |
-3.89 |
|
|
|
|
|
|
